From: Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy
Components | Characteristics | Role in STING pathway |
---|---|---|
cGAS | An evolutionarily conserved cytosolic DNA sensor | It uses ATP and GTP as substrates to catalyze the synthesis of cGAMP |
cGAMP | A cyclic dinucleotide second messenger | It binds to STING localized on the ER membrane, which promotes STING oligomerization and translocation from the ER to the Golgi apparatus |
STING | An ER membrane protein as a key adaptor in innate immunity, | Its oligomerization recruits TBK1 and further triggers IRF3- and NF-κB-dependent transcription of type I IFNs |
TBK1 | A serine/threonine kinase | It phosphorylates STING and subsequently activates both IRF3 and NF-κB |
IRF3 | A transcription regulator | After phosphorylated by TBK1, it subsequently translocates to the nucleus, where it induces the transcription of inflammatory factors |
NF-κB | A transcription regulator | After activated byTBK1 and IκB kinase epsilon, it synergizes with IRF3 to induce the transcription of inflammatory factors |
Type I IFNs | Major downstream molecules (IFN-α and IFN-β) of STING pathway | IFN-α and IFN-β involve in host innate immune activation |
Other proinflammatory factors | Inflammatory cytokines (such as TNF, IL-6 and IL-12) and chemokines (such as CXCL9 and CXCL10) | The STING activation is also required for the induction of many other genes encodings proinflammatory factors that regulates both innate and adaptive immunity |